Brown Advisory Inc. Increases Stake in iShares Dow Jones US Pharm Indx (IHE)

Brown Advisory Inc. lifted its position in iShares Dow Jones US Pharm Indx (NYSEARCA:IHE) by 4.7% in the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 64,047 shares of the company’s stock after acquiring an additional 2,850 shares during the period. Brown Advisory Inc.’s holdings in iShares Dow Jones US Pharm Indx were worth $10,751,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the company. Morgan Stanley raised its position in shares of iShares Dow Jones US Pharm Indx by 4.8% in the 2nd quarter. Morgan Stanley now owns 295,105 shares of the company’s stock worth $44,667,000 after acquiring an additional 13,514 shares in the last quarter. Cornerstone Wealth Management LLC bought a new position in shares of iShares Dow Jones US Pharm Indx in the 2nd quarter worth approximately $169,000. CIBC World Markets Inc. bought a new position in shares of iShares Dow Jones US Pharm Indx in the 3rd quarter worth approximately $4,110,000. Karp Capital Management Corp raised its position in shares of iShares Dow Jones US Pharm Indx by 704.8% in the 2nd quarter. Karp Capital Management Corp now owns 20,120 shares of the company’s stock worth $3,045,000 after acquiring an additional 17,620 shares in the last quarter. Finally, Wesbanco Bank Inc. bought a new position in shares of iShares Dow Jones US Pharm Indx in the 3rd quarter worth approximately $638,000.

Shares of NYSEARCA:IHE opened at $157.57 on Monday. iShares Dow Jones US Pharm Indx has a 52-week low of $139.28 and a 52-week high of $170.26.

ILLEGAL ACTIVITY WARNING: “Brown Advisory Inc. Increases Stake in iShares Dow Jones US Pharm Indx (IHE)” was originally posted by Community Financial News and is the property of of Community Financial News. If you are reading this article on another publication, it was illegally copied and republished in violation of United States & international trademark and copyright law. The legal version of this article can be read at https://www.com-unik.info/2018/12/03/brown-advisory-inc-increases-stake-in-ishares-dow-jones-us-pharm-indx-ihe.html.

iShares Dow Jones US Pharm Indx Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.

Further Reading: What is a closed-end mutual fund (CEF)?

Want to see what other hedge funds are holding IHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Dow Jones US Pharm Indx (NYSEARCA:IHE).

Institutional Ownership by Quarter for iShares Dow Jones US Pharm Indx (NYSEARCA:IHE)

Receive News & Ratings for iShares Dow Jones US Pharm Indx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Dow Jones US Pharm Indx and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit